Members Login
 

The WHO Early Release Guideline on ARV and PrEP

were published on September

30th, 2015 and can be

found here:

 Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

JIAS Special Issue: PrEP Implementation Science: State-of-the-Art and Research Agenda, organized by NEMUS (published July 2015).

 Please visit Nemus´Youtube channell

 

Follow us in Facebook

 

and Twiter

Agenda

Wednesday, 17 February 2016 22:20

HIV & Hepatitis Clinical Pharmacology Workshop 2016

The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.

 

The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will be held 8 - 10 June 2016 in Washington DC, USA.

 

 

Understanding the clinical pharmacology of antiretroviral therapy is pivotal to designing optimal treatment and prevention strategies for HIV & Hepatitis infection. Drug exposure is significantly influenced by drug interactions, medication taking behavior, and patients’ physiologic and genetic characteristics. These factors are central to determining therapeutic efficacy, failure or toxicity. Despite great progress, many pharmacologic challenges still exist.

 

The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiretroviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance project, and regulatory considerations.

 

The Clinical Pharmacology workshop is a unique platform where industry pharmacologist and academic pharmacologists sharing and discussing the latest developments in clinical pharmacology. Improved knowledge on drug efficacy/toxicity and potential drug interactions enables clinicians to further optimize antiviral treatment for their HIV and/or Hepatitis infected patients.

 

The 17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will be held 8 - 10 June 2016 in Washington DC, USA.

http://www.virology-education.com/event/upcoming/17th-international-workshop-on-clinical-pharmacology-of-hiv-hepatitis-therapy/

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn
Read 763 times Last modified on Wednesday, 17 February 2016 22:26